Digg StumbleUpon LinkedIn YouTube Flickr Facebook Twitter RSS Reset
Comments Off

HEMATOLOGY MCQ – Exercise 36

The multiple choice questions in this online test paper focuses on HEMATOLOGY MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online HEMATOLOGY MCQ Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 22 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. true regarding streptokinase

 
 
 
 

Q 2. warfarin induced skin necrosis occurs in which week of therapy

 
 
 
 

Q 3. true statement regarding warfarin

 
 
 
 

Q 4. half life of t-PA (tissue plasminogen activator) is

 
 
 
 

Q 5. oral anticoagulants include

 
 
 
 

Q 6. bolus fibrinolytic agent includes

 
 
 
 

Q 7. following is direct fibrinolytic agent

 
 
 
 

Q 8. recombinant derivative of recombinant tissue type plasminogen activator (rt-PA) is

 
 
 
 

Q 9. fibrin specific plasminogen activators include

 
 
 
 

Q 10. warfarin embryopathy is due to effect of warfarin on which bone matrix protein

 
 
 
 

Q 11. urokinase derived from

 
 
 
 

Q 12. half life of urokinase is

 
 
 
 

Q 13. warfarin induced skin necrosis is seen in patients with congenital or acquired deficiencies of

 
 
 
 

Q 14. initial treatment with warfarin is supported by concomitant administration of which of the following

 
 
 
 

Q 15. streptokinase binds to which of the following

 
 
 
 

Q 16. true regarding streptokinase

 
 
 
 

Q 17. risk of intracranial hemorrhage with use of thrombolytic agents is increased in all except

 
 
 
 

Q 18. Paget-Schroetter syndrome relates to

 
 
 
 

Q 19. Purple Toe syndrome is seen in patients receiving warfarin with

 
 
 
 

Q 20. patients on warfarin with serious bleeding are treated with

 
 
 
 

Q 21. for prevention or treatment of thrombosis in pregnancy following can be given during pregnancy

 
 
 
 

Q 22. risk of warfarin embryopathy is greatest in which trimester of pregnancy

 
 
 
 


Comments are closed.